These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 18629353)

  • 1. Endothelial effects of antihypertensive treatment: focus on irbesartan.
    Negro R
    Vasc Health Risk Manag; 2008; 4(1):89-101. PubMed ID: 18629353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers.
    Sakuta T; Morita Y; Satoh M; Fox DA; Kashihara N
    Arthritis Rheum; 2010 May; 62(5):1319-28. PubMed ID: 20213806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microparticles and endothelial progenitor cells in atherosclerosis: pharmacological effects of irbesartan.
    Georgescu A; Alexandru N; Andrei E; Titorencu I; Dragan E; Tarziu C; Ghiorghe S; Badila E; Bartos D; Popov D
    J Thromb Haemost; 2012 Apr; 10(4):680-91. PubMed ID: 22303879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type I receptor blocker and endothelial function in humans: role of nitric oxide and oxidative stress.
    Higashi Y; Chayama K; Yoshizumi M
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):133-48. PubMed ID: 15853700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation in hypertension associated with hypercholesterolemia: effects of irbesartan.
    Alexandru N; Popov D; Dragan E; Andrei E; Georgescu A
    J Thromb Haemost; 2011 Jan; 9(1):173-84. PubMed ID: 20961397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
    Tiryaki O; Usalan C; Buyukhatipoglu H; Sayiner ZA; Kilisli H
    Clin Exp Hypertens; 2012; 34(2):145-52. PubMed ID: 21967026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term irbesartan treatment on endothelium-dependent vasodilation in essential hypertensive patients.
    Bragulat E; Larrousse M; Coca A; de la Sierra A
    Br J Biomed Sci; 2003; 60(4):191-6. PubMed ID: 14725334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
    Pu Q; Larouche I; Schiffrin EL
    Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis related gene expression profiles of EA.hy926 cells induced by irbesartan: a possible novel therapeutic approach.
    Ma C; Lu XC; Luo Y; Cao J; Yang B; Gao Y; Liu XF; Fan L
    Chin Med J (Engl); 2012 Apr; 125(8):1369-75. PubMed ID: 22613637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor blocker irbesartan ameliorates vascular function in spontaneously hypertensive rats regardless of oestrogen status.
    Riveiro A; Mosquera A; Alonso M; Calvo C
    J Hypertens; 2002 Jul; 20(7):1365-72. PubMed ID: 12131533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats.
    Wassmann S; Bäumer AT; Strehlow K; van Eickels M; Grohé C; Ahlbory K; Rösen R; Böhm M; Nickenig G
    Circulation; 2001 Jan; 103(3):435-41. PubMed ID: 11157697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.
    Ruilope L
    J Hypertens Suppl; 1997 Dec; 15(7):S15-20. PubMed ID: 9532516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of action of angiotensin II is dependent on direct activation of vascular smooth muscle carbonic anhydrase I.
    Puscas I; Coltau M; Gilau L; Baican M; Pasca R; Domuta G; Hecht A
    Int J Clin Lab Res; 2000; 30(3):119-25. PubMed ID: 11196069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction.
    Oelze M; Mollnau H; Hoffmann N; Warnholtz A; Bodenschatz M; Smolenski A; Walter U; Skatchkov M; Meinertz T; Münzel T
    Circ Res; 2000 Nov; 87(11):999-1005. PubMed ID: 11090544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
    Schiffrin EL
    Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
    Garcia V; Joseph G; Shkolnik B; Ding Y; Zhang FF; Gotlinger K; Falck JR; Dakarapu R; Capdevila JH; Bernstein KE; Schwartzman ML
    Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(1):R71-8. PubMed ID: 25924878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation.
    Clancy P; Koblar SA; Golledge J
    Atherosclerosis; 2014 Sep; 236(1):108-15. PubMed ID: 25016365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of omapatrilat and irbesartan/hydrochlorothiazide on endothelial function and cardiac hypertrophy in the stroke-prone spontaneously hypertensive rat: sex differences.
    Graham D; Hamilton C; Beattie E; Spiers A; Dominiczak AF
    J Hypertens; 2004 Feb; 22(2):329-37. PubMed ID: 15076191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.